|
|
|
|
|
|
|
||
| ||||||||||||||||||||||||||
Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20072509
Rolny et al. • Figure S1 NP expression in human cancer cells.
• Figure S2 SEMA3B expression in human tumors.
• Figure S3 NP1, but not NP2, is required for SEMA3B-mediated growth inhibition.
• Figure S4 IL-8 stimulates the migration of monocytes.
• Figure S5 RNAi-mediated knock down of endogenous SEMA3B suppresses IL-8 production in tumor cells.
• Figure S6 SEMA3B-repelling activity on endothelial cells.
• Figure S7 SEMA3B expression does not increase the formation of lung colonies upon tail vein injection of transduced tumor cells.
• Figure S8 SEMA3B expression in human melanoma samples correlates with the expression of CD14 macrophage marker and elevated IL-8 levels.
• Figure S9 VEGF expression in tumor cells is not affected by SEMA3B.
• Table S1 (PDF)
• Supplemental text (PDF)
| ||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|
